Management of Hormonal Therapy for the Treatment of Advanced Hormone-Dependent Prostate Cancer: A Pharmacoeconomics Assessment of the Use of Degarelix – Firmagon® Compared to Generic Triptorelin. Acta Med Peru 2024, 28 (4), 188-193.